Kam Sprott

1.5k total citations
31 papers, 1.2k citations indexed

About

Kam Sprott is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kam Sprott has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Kam Sprott's work include Gastrointestinal Tumor Research and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and DNA Repair Mechanisms (4 papers). Kam Sprott is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and DNA Repair Mechanisms (4 papers). Kam Sprott collaborates with scholars based in United States, France and United Kingdom. Kam Sprott's co-authors include Lewis C. Cantley, A. John Rush, Joan MacNeill, Jian Ren, Michael J. Comb, Steven P. Gygi, William E. Pierceall, Jessica E. Hutti, William C. Hahn and Rhine R. Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kam Sprott

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kam Sprott United States 12 756 376 276 156 130 31 1.2k
Alberto Peláez‐García Spain 21 821 1.1× 326 0.9× 323 1.2× 149 1.0× 79 0.6× 44 1.3k
Christopher J. Tape United Kingdom 20 548 0.7× 637 1.7× 235 0.9× 236 1.5× 174 1.3× 36 1.3k
Ann C. Mladek United States 20 1000 1.3× 473 1.3× 282 1.0× 83 0.5× 62 0.5× 41 1.5k
Jacqueline Lesperance United States 16 819 1.1× 478 1.3× 205 0.7× 248 1.6× 143 1.1× 25 1.2k
Jun Nakayama Japan 19 752 1.0× 250 0.7× 178 0.6× 249 1.6× 88 0.7× 51 1.1k
Julia V. Burnier Canada 21 592 0.8× 408 1.1× 318 1.2× 174 1.1× 67 0.5× 73 1.2k
Mikkel G. Terp Denmark 19 637 0.8× 404 1.1× 342 1.2× 270 1.7× 57 0.4× 42 1.2k
Yelena Mironchik United States 19 797 1.1× 436 1.2× 386 1.4× 151 1.0× 78 0.6× 38 1.3k
Cheryl A. Sherman‐Baust United States 15 1.2k 1.6× 417 1.1× 701 2.5× 273 1.8× 155 1.2× 16 1.9k
Sanjeev Balakrishnan United States 8 1.0k 1.4× 572 1.5× 667 2.4× 94 0.6× 132 1.0× 9 1.5k

Countries citing papers authored by Kam Sprott

Since Specialization
Citations

This map shows the geographic impact of Kam Sprott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kam Sprott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kam Sprott more than expected).

Fields of papers citing papers by Kam Sprott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kam Sprott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kam Sprott. The network helps show where Kam Sprott may publish in the future.

Co-authorship network of co-authors of Kam Sprott

This figure shows the co-authorship network connecting the top 25 collaborators of Kam Sprott. A scholar is included among the top collaborators of Kam Sprott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kam Sprott. Kam Sprott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
George, Suzanne, Jean‐Yves Blay, Ping Chi, et al.. (2024). The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations. Future Oncology. 20(27). 1973–1982. 4 indexed citations
3.
4.
Trent, Jonathan C., Robin L. Jones, Suzanne George, et al.. (2023). Outcomes in patients with advanced gastrointestinal stromal tumor who did not have baseline ctDNA detected in the INTRIGUE study.. Journal of Clinical Oncology. 41(16_suppl). 11536–11536. 1 indexed citations
5.
6.
Brown, Jennifer R., Ian W. Flinn, Matthew S. Davids, et al.. (2018). Clinical and Biological Indicators of Duvelisib Efficacy in CLL from the Phase 3 DUOTM Study. Blood. 132(Supplement 1). 1856–1856. 2 indexed citations
7.
Weaver, David T., Kam Sprott, Jonathan A. Pachter, et al.. (2018). Duvelisib inhibition of chemokines in patients with CLL (DUO study) and iNHL (DYNAMO study).. Journal of Clinical Oncology. 36(15_suppl). 12048–12048. 2 indexed citations
8.
Andtbacka, Robert H.I., Robert H. Pierce, Jean S. Campbell, et al.. (2018). Abstract 613: X4P-001, an orally bioavailable CXCR4 antagonist, enhances immune cell infiltration and activation in the tumor microenvironment of melanoma. Cancer Research. 78(13_Supplement). 613–613. 9 indexed citations
9.
Bueno, Raphael, Ritu R. Gill, Patrick H. Lizotte, et al.. (2017). Effect of FAK inhibitor defactinib on tumor immune changes and tumor reductions in a phase II window of opportunity study in malignant pleural mesothelioma (MPM).. Journal of Clinical Oncology. 35(15_suppl). 8555–8555. 8 indexed citations
10.
Seiwert, Tanguy Y., Kam Sprott, Stephen P. Finn, et al.. (2014). DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer. PLoS ONE. 9(7). e102112–e102112. 13 indexed citations
11.
Fagerholm, Rainer, Kam Sprott, Tuomas Heikkinen, et al.. (2013). Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer. Annals of Oncology. 24(11). 2780–2785. 27 indexed citations
12.
Harris, Jennifer L., et al.. (2013). Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells. Drug Development Research. 74(2). 138–147. 4 indexed citations
13.
Pierceall, William E., Ken A. Olaussen, Vanessa Rousseau, et al.. (2012). Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses. Annals of Oncology. 23(9). 2245–2252. 54 indexed citations
14.
Pierceall, William E., Kam Sprott, Tuomas Heikkinen, et al.. (2011). Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer. Human Pathology. 43(9). 1363–1375. 2 indexed citations
15.
Pierceall, William E., Yan Chen, Kam Sprott, et al.. (2011). Strategies for H-score normalization of preanalytical technical variables with potential utility to immunohistochemical-based biomarker quantitation in therapeutic response diagnostics.. SHILAP Revista de lepidopterología. 34(3). 159–68. 24 indexed citations
16.
Alexander, Brian M., Kam Sprott, XiaoZhe Wang, et al.. (2010). DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer. Clinical Cancer Research. 16(23). 5796–5804. 27 indexed citations
17.
Aslan, Joseph E., Huihong You, Jessica Endig, et al.. (2009). Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis. Molecular Cell. 34(4). 497–509. 63 indexed citations
18.
Hutti, Jessica E., Rhine R. Shen, Derek W. Abbott, et al.. (2009). Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation. Molecular Cell. 34(4). 461–472. 184 indexed citations
19.
Sprott, Kam, et al.. (2009). DNA repair protein biomarkers in triple negative breast cancer.. Cancer Research. 69(2_Supplement). 1064–1064. 2 indexed citations
20.
Stokes, Matthew P., A. John Rush, Joan MacNeill, et al.. (2007). Profiling of UV-induced ATM/ATR signaling pathways. Proceedings of the National Academy of Sciences. 104(50). 19855–19860. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Peláez‐García Breakdown of academic impact, for papers by Christopher J. Tape Breakdown of academic impact, for papers by Ann C. Mladek Breakdown of academic impact, for papers by Jacqueline Lesperance Breakdown of academic impact, for papers by Jun Nakayama Breakdown of academic impact, for papers by Julia V. Burnier Breakdown of academic impact, for papers by Mikkel G. Terp Breakdown of academic impact, for papers by Yelena Mironchik Breakdown of academic impact, for papers by Cheryl A. Sherman‐Baust Breakdown of academic impact, for papers by Sanjeev Balakrishnan
Rankless by CCL
2026